Drug information for MYCIFRADIN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SOLUTION; ORAL
EQ 87.5MG BASE/5ML
Discontinued
NEOMYCIN SULFATE
Neomycin
PHARMACIA AND UPJOHN
50285
TABLET; ORAL
EQ 350MG BASE
Discontinued
NEOMYCIN SULFATE
Neomycin
PHARMACIA AND UPJOHN
60520
Drug Adverse Effects information for MYCIFRADIN
Role code
Indications
Reaction
# Reports
C
LAPAROSCOPIC SURGERY
ANAEMIA
1
C
LAPAROSCOPIC SURGERY
ANXIETY
1
C
LAPAROSCOPIC SURGERY
DEHYDRATION
1
C
LAPAROSCOPIC SURGERY
HYPOVOLAEMIA
1
C
LAPAROSCOPIC SURGERY
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
1
C
LAPAROSCOPIC SURGERY
POST PROCEDURAL COMPLICATION
1
C
LAPAROSCOPIC SURGERY
RENAL FAILURE ACUTE
1
C
LAPAROSCOPIC SURGERY
RENAL TUBULAR NECROSIS
1
Ads by Google